DK1534237T3 - Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf - Google Patents

Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1534237T3
DK1534237T3 DK03757165T DK03757165T DK1534237T3 DK 1534237 T3 DK1534237 T3 DK 1534237T3 DK 03757165 T DK03757165 T DK 03757165T DK 03757165 T DK03757165 T DK 03757165T DK 1534237 T3 DK1534237 T3 DK 1534237T3
Authority
DK
Denmark
Prior art keywords
processes
preparation
soluble tablets
orally soluble
orally
Prior art date
Application number
DK03757165T
Other languages
Danish (da)
English (en)
Inventor
Ferran Javier Segado
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29724735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1534237(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Application granted granted Critical
Publication of DK1534237T3 publication Critical patent/DK1534237T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03757165T 2002-06-10 2003-06-04 Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf DK1534237T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200201440A ES2199061B1 (es) 2002-06-10 2002-06-10 Comprimidos bucodispersables y procedimiento para su obtencion.
PCT/IB2003/002446 WO2003103629A1 (en) 2002-06-10 2003-06-04 Orally disintegrating tablets and process for obtaining them.

Publications (1)

Publication Number Publication Date
DK1534237T3 true DK1534237T3 (da) 2009-05-04

Family

ID=29724735

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03757165T DK1534237T3 (da) 2002-06-10 2003-06-04 Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf

Country Status (33)

Country Link
US (1) US20060165781A1 (pl)
EP (1) EP1534237B1 (pl)
JP (1) JP2005533045A (pl)
KR (1) KR100826819B1 (pl)
CN (1) CN100428926C (pl)
AR (1) AR040183A1 (pl)
AT (1) ATE422154T1 (pl)
AU (1) AU2003232415B2 (pl)
BR (1) BR0311708A (pl)
CA (1) CA2487834C (pl)
CY (1) CY1108961T1 (pl)
DE (1) DE60326074D1 (pl)
DK (1) DK1534237T3 (pl)
EG (1) EG25919A (pl)
ES (2) ES2199061B1 (pl)
HK (1) HK1076252A1 (pl)
HR (1) HRP20041158B1 (pl)
IL (1) IL165523A (pl)
JO (1) JO2560B1 (pl)
MA (1) MA27309A1 (pl)
MX (1) MXPA04012464A (pl)
MY (1) MY139585A (pl)
NO (1) NO334159B1 (pl)
NZ (1) NZ536966A (pl)
PE (1) PE20040069A1 (pl)
PL (1) PL207009B1 (pl)
PT (1) PT1534237E (pl)
RU (1) RU2321389C2 (pl)
SA (1) SA03240275B1 (pl)
SI (1) SI1534237T1 (pl)
TW (1) TWI288002B (pl)
WO (1) WO2003103629A1 (pl)
ZA (1) ZA200409894B (pl)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
EP1128817A1 (en) * 1998-10-27 2001-09-05 Biovail Technologies Ltd Microparticles containing peg and/or peg glyceryl esters
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EP1670441A4 (en) * 2003-10-07 2012-05-02 Andrx Pharmaceuticals Llc FAST RESOLUTION FORMULATION
ES2238001B1 (es) 2004-01-21 2006-11-01 Vita Cientifica, S.L. Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
JP2005306770A (ja) * 2004-04-21 2005-11-04 Toa Eiyo Ltd 口腔内速崩壊型製剤及びその製造方法
IS7290A (is) * 2004-05-28 2005-11-29 Actavis Group Lyfjasamsetningar sem innihalda risperidone
DE102004034043A1 (de) * 2004-07-13 2006-02-09 Krka Tovarna Zdravil, D.D. Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
GB0423800D0 (en) * 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
WO2006087629A2 (en) * 2005-02-21 2006-08-24 Aurobindo Pharma Limited Rapidly disintegrating composition of olanzapine
TWI383809B (zh) * 2005-06-29 2013-02-01 Otsuka Pharma Co Ltd 含有西洛他唑（ｃｉｌｏｓｔａｚｏｌ）之口腔崩解粉末
US20070092586A1 (en) * 2005-10-26 2007-04-26 Alamo Pharmaceuticals Compositions and methods for the administration psychotropic drugs which modulate body weight
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
CN100457100C (zh) * 2005-12-23 2009-02-04 北京科信必成医药科技发展有限公司 甲氧氯普胺口腔崩解片及其生产方法
CN100360128C (zh) * 2005-12-23 2008-01-09 北京科信必成医药科技发展有限公司 石杉碱甲口腔崩解片及其制备方法
EP1852108A1 (en) * 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CA2810295C (en) 2006-05-04 2017-11-14 Boehringer Ingelheim International Gmbh A polymeric form of 1-((4-methyl-quinazolin-2-yl)methyl)-3-7-(2-butyn-1-yl)-8-(3-(r)-aminopiperidin-1-yl)xanthine
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
EP2076250B1 (en) * 2006-10-27 2011-01-05 FMC Corporation Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
TWI547282B (zh) * 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 樂命達之口服分解錠劑組合物
CA2703501C (en) 2007-10-01 2017-06-13 Laboratorios Lesvi, S.L. Orodispersible tablets
GB2458403B (en) 2007-11-13 2010-01-13 Meritage Pharma Inc Stabilised corticosteroid compositions
CA2705884A1 (en) * 2007-11-14 2009-05-22 Manuel Gidekel New extracts of deschampsia antarctica desv. with antineoplastic activity
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
BRPI0914164B1 (pt) 2008-06-20 2019-04-30 Merck Patent Gmbh Comistura para produção de comprimidos de desintegração rápida em um processo de formação de comprimido direto, seus usos, e formulações de comprimido
FR2933299B1 (fr) 2008-07-04 2012-02-03 Roquette Freres Mannitol orodispersible
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
KR101033975B1 (ko) * 2008-10-10 2011-05-11 이희엽 직접압축법을 이용한 발사르탄 함유 고형 경구 제형의 제조방법 및 이에 따라 제조된 고형 경구 제형
EP2198857A1 (en) 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
DE102009016584A1 (de) * 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
CN101874790B (zh) * 2009-04-29 2012-06-06 齐鲁制药有限公司 雷沙吉兰或者其药用盐口腔崩解片及其制备方法
CN101904824B (zh) * 2009-06-04 2012-07-18 齐鲁制药有限公司 奥氮平口崩片制剂及其制备方法
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
US20110105441A1 (en) * 2009-10-30 2011-05-05 Fmc Corporation Stable Orally Disintegrating Tablets Having Low Superdisintegrant
CA2782179C (en) 2009-11-27 2020-06-23 Boehringer Ingelheim International Gmbh Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
US20110150993A1 (en) * 2009-12-22 2011-06-23 Fmc Corporation Fine Particle Croscarmellose and Uses Thereof
WO2011138797A2 (en) 2010-05-04 2011-11-10 Cadila Healthcare Limited Delayed release oral disintegrating pharmaceutical compositions of lansoprazole
ES2935300T3 (es) 2010-05-05 2023-03-03 Boehringer Ingelheim Int Combiterapia
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP6084826B2 (ja) * 2012-11-27 2017-02-22 古河産機システムズ株式会社 造粒物検査装置および造粒物の検査方法
WO2016126012A1 (en) * 2015-02-05 2016-08-11 Boryung Pharmaceutical Co., Ltd Tablet and method of preparing the same
KR101545268B1 (ko) 2015-02-05 2015-08-20 보령제약 주식회사 정제 및 이의 제조방법
WO2017038455A1 (ja) * 2015-09-04 2017-03-09 株式会社ダイセル 超速崩壊錠剤及びその製造方法
CN107789328B (zh) * 2016-09-07 2021-02-26 成都康弘药业集团股份有限公司 一种含有盐酸多奈哌齐的口崩片及其制备方法
KR102290312B1 (ko) 2017-04-10 2021-08-17 주식회사 엘지생활건강 정제 조성물 및 이의 제조방법
WO2019004155A1 (ja) * 2017-06-27 2019-01-03 第一三共株式会社 錠剤
EP4078055A4 (en) * 2019-12-16 2024-03-27 Northwestern University FREEZE DRIED REAGENTS
CN113730365A (zh) * 2021-08-10 2021-12-03 杭州新诺华医药有限公司 一种奥氮平口腔崩解片及其制备方法
CN114224855B (zh) * 2021-12-01 2023-11-28 北京悦康科创医药科技股份有限公司 一种甲磺酸多沙唑嗪口含片及其制备方法
GB2627294A (en) * 2023-02-20 2024-08-21 Novumgen Ltd A fast-disintegrating tablet of bisoprolol or pharmaceutically acceptable salts thereof and its process of preparation
CN116251067B (zh) * 2023-04-23 2024-06-07 淄博市中心医院 一种氟康唑片、制备方法及用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272265B1 (de) * 1985-09-25 1991-05-22 Gergely, Gerhard, Dr. Zerfallstablette und verfahren zu ihrer herstellung
IT1238072B (it) * 1990-01-19 1993-07-03 Sclavo Spa Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
FR2710637B1 (fr) * 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
FR2722408B1 (fr) * 1994-07-15 1996-10-04 Vacher Dominique Nouveau procede de realisation de formes pharmaceutiques seches a delitement quasiment instantane etles formes pharmaceutiques ainsi realisees
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JPH10298062A (ja) * 1997-04-24 1998-11-10 Pfizer Pharmaceut Co Ltd 口腔内速溶型錠剤
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
WO2000078292A1 (fr) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Preparations solides a desintegration rapide
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
WO2001012161A1 (en) * 1999-08-17 2001-02-22 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
CA2342121C (fr) * 2000-03-29 2010-05-25 Roquette Freres Mannitol pulverulent et son procede de preparation

Also Published As

Publication number Publication date
SA03240275B1 (ar) 2008-11-19
AR040183A1 (es) 2005-03-16
BR0311708A (pt) 2005-03-15
IL165523A (en) 2011-07-31
RU2004135377A (ru) 2005-09-10
ES2199061B1 (es) 2005-02-16
MY139585A (en) 2009-10-30
PL207009B1 (pl) 2010-10-29
TW200403080A (en) 2004-03-01
AU2003232415B2 (en) 2008-05-15
HK1076252A1 (en) 2006-01-13
RU2321389C2 (ru) 2008-04-10
NO20045577L (no) 2004-12-21
KR20050062467A (ko) 2005-06-23
JP2005533045A (ja) 2005-11-04
HRP20041158A2 (en) 2005-04-30
CN100428926C (zh) 2008-10-29
KR100826819B1 (ko) 2008-05-02
WO2003103629A1 (en) 2003-12-18
EG25919A (en) 2012-10-15
ATE422154T1 (de) 2009-02-15
IL165523A0 (en) 2006-01-15
HRP20041158B1 (en) 2012-11-30
TWI288002B (en) 2007-10-11
EP1534237A1 (en) 2005-06-01
DE60326074D1 (de) 2009-03-19
AU2003232415A1 (en) 2003-12-22
PL374197A1 (pl) 2005-10-03
NO334159B1 (no) 2013-12-23
PE20040069A1 (es) 2004-03-25
ES2199061A1 (es) 2004-02-01
CA2487834A1 (en) 2003-12-18
EP1534237B1 (en) 2009-02-04
ES2320753T3 (es) 2009-05-28
NZ536966A (en) 2006-08-31
MXPA04012464A (es) 2005-06-08
CA2487834C (en) 2009-07-14
PT1534237E (pt) 2009-05-05
JO2560B1 (en) 2010-09-05
CN1658838A (zh) 2005-08-24
CY1108961T1 (el) 2014-07-02
MA27309A1 (fr) 2005-05-02
SI1534237T1 (sl) 2009-06-30
US20060165781A1 (en) 2006-07-27
ZA200409894B (en) 2006-05-31

Similar Documents

Publication Publication Date Title
DK1534237T3 (da) Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf
NO20052335D0 (no) Dispergerbare defracirox-tabletter
DK1753406T4 (da) Overtrukket tabletformulering og fremgangsmåde
IS2504B (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
DK1562573T3 (da) Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf
DK1480622T3 (da) Farmaceutiske, granulære immediate release-præparater og en kontinuert fremgangsmåde til fremstilling deraf
NO20055393D0 (no) Oralt desintegrerende tabletter
DK1673349T3 (da) Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
DK1628547T3 (da) Oralt snusprodukt og fremgangsmåde til fremstilling deraf
NO20031776D0 (no) Null-boringskomplettering og produksjonssystem
DE60210315D1 (de) Tamsulosin tabletten
IS7594A (is) Laxófoxifen tafla og húðun hennar
DK1620551T3 (da) Phospholipase og fremgangsmåde til fremstilling deraf
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
ATE388693T1 (de) Wohlschmeckende kautablette
NO20053809D0 (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
DK1560826T3 (da) Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
DK2085395T3 (da) Arylvinylazacycloalkan-forbindelser og fremgangsmåder til fremstilling og anvendelser deraf
NO20043349L (no) Kumarinderivater, fremgangsmate for deres framstilling og anvendelse derav
DK1558612T3 (da) Imidazopyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
NO20043333L (no) Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem
DK1742927T3 (da) Butanonsyrederivater, fremgangsmåder til fremstilling deraf, farmaceutiske præparater omfattende dem, og farmaceutiske applikationer deraf
DK1819320T3 (da) Oralt dispergerbar farmaceutisk sammensætning og fremgangsmåde til fremstilling heraf
NO20042890L (no) Farmasoytiske preparater og fremgangsmate for fremstilling derav
NO20053805D0 (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav